Effect of efavirenz on the pharmacokinetics of ketoconazole in HIV-infected patients

By Sriwiriyajan Somchai   Mahatthanatrakul Werawath   Ridtitid Wibool   Jaruratanasirikul Sutep  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 5, 2007-05 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

High Variability of Indinavir and Nelfinavir Pharmacokinetics in HIV-Infected Patients with a Sustained Virological Response on Highly Active Antiretroviral Therapy

By Goujard Cécile  

Clinical Pharmacokinetics, Vol. 44, Iss. 12, 2005-01 ,pp. : 1267-1278

Adis International

Access to resources Recommend Favorite

Multiple-Dose Pharmacokinetics of Delavirdine Mesylate and Didanosine in HIV-Infected Patients

By Morse G.D.  

Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. : 323-328

Adis International

Access to resources Recommend Favorite

Influence of tenofovir, nevirapine and efavirenz on ritonavir-boosted atazanavir pharmacokinetics in HIV-infected patients

By Dailly Eric   Tribut Olivier   Tattevin Pierre   Arvieux Cédric   Perré Philippe   Raffi François   Jolliet Pascale  

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 523-526

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetic Interactions Between Efavirenz and Rifampicin in HIV-Infected Patients with Tuberculosis

By López-Cortés L.F.  

Clinical Pharmacokinetics, Vol. 41, Iss. 9, 2002-01 ,pp. : 681-690

Adis International

Access to resources Recommend Favorite